RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Aceso Life Science Group Stock

Aceso Life Science Group Market capitalization 2024

Aceso Life Science Group Market capitalization

385.52 M HKD

Ticker

474.HK

ISIN

KYG0070S1066

In 2024, Aceso Life Science Group's market cap stood at 385.52 M HKD, a -54.59% increase from the 848.89 M HKD market cap in the previous year.

The Aceso Life Science Group Market capitalization history

YEARMarket Capitalization (undefined HKD)
20240.39
20231.07
20220.88
20211.41
20201.46
20191.09
20181.31
20171.4
20161.38
20151.4
20140.85
20131.43
20120.67
20111.32
20100.61
20090.36
20080.24
20070.24
20060.14
2005-

Aceso Life Science Group Aktienanalyse

What does Aceso Life Science Group do?

Aceso Life Science Group Ltd is a UK-based company specializing in the field of medical cannabis. The company was founded in 2016 when the founders recognized the growing demand for medical cannabis and decided to utilize their expertise in this area to establish a company focused on the development and marketing of cannabis products. Aceso's business model is based on various pillars. On one hand, the company offers product design and research and development in the field of medical cannabis products. Aceso also provides various services to help other companies and research institutions develop and bring their own commercial products to market. The company also has a strong presence in retail, where it offers a wide range of cannabinoid products. Aceso Life Science Group has various divisions that focus on the production of medical cannabis products. This includes the manufacturing of medical cannabinoids, which involves the preparation of cannabis oil and other products. Aceso also offers various types of medical cannabis, such as different THC and CBD-based products, and has also developed a special line of products targeting women. Aceso also has a strong presence in research and development, with a dedicated department focused on the development of new and improved cannabinoid products. Aceso's research department works closely with academic research institutions and other organizations to investigate and improve the efficacy and safety of medical cannabis and its derivatives. The products offered by Aceso primarily include medical oils, capsules, tinctures, and creams. These products contain a wide range of cannabinoids, such as CBD, THC, CBG, and CBN, which can be used to treat various conditions. Aceso has also developed a special series of products targeting women, including specific vaginal creams that can be used to treat pain and discomfort associated with the menstrual cycle and other conditions. Overall, Aceso Life Science Group Ltd has established itself as a leading company in the field of medical cannabis products. The company has developed a wide range of products and services aimed at providing its customers with a safe and effective way to treat various conditions. With a strong retail presence and a dedicated research department, Aceso has everything it needs to continue to play a pioneering role in the medical cannabis industry. Aceso Life Science Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Aceso Life Science Group's Market Capitalization

Aceso Life Science Group's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Aceso Life Science Group's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Aceso Life Science Group's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Aceso Life Science Group’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Aceso Life Science Group stock

What is the current Aceso Life Science Group market capitalization?

The current market capitalization of Aceso Life Science Group is 385.52 M HKD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Aceso Life Science Group.

How has the market capitalization of Aceso Life Science Group developed in recent years?

The market capitalization of Aceso Life Science Group has increased/decreased by -54.59% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Aceso Life Science Group?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Aceso Life Science Group?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Aceso Life Science Group have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Aceso Life Science Group pay?

Over the past 12 months, Aceso Life Science Group paid a dividend of 0.02 HKD . This corresponds to a dividend yield of about 42.38 %. For the coming 12 months, Aceso Life Science Group is expected to pay a dividend of 0 HKD.

What is the dividend yield of Aceso Life Science Group?

The current dividend yield of Aceso Life Science Group is 42.38 %.

When does Aceso Life Science Group pay dividends?

Aceso Life Science Group pays a quarterly dividend. This is distributed in the months of September, September, September, September.

How secure is the dividend of Aceso Life Science Group?

Aceso Life Science Group paid dividends every year for the past 0 years.

What is the dividend of Aceso Life Science Group?

For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aceso Life Science Group located?

Aceso Life Science Group is assigned to the 'Finance' sector.

Wann musste ich die Aktien von Aceso Life Science Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aceso Life Science Group from 9/2/2009 amounting to 0.012 HKD, you needed to have the stock in your portfolio before the ex-date on 8/14/2009.

When did Aceso Life Science Group pay the last dividend?

The last dividend was paid out on 9/2/2009.

What was the dividend of Aceso Life Science Group in the year 2023?

In the year 2023, Aceso Life Science Group distributed 0 HKD as dividends.

In which currency does Aceso Life Science Group pay out the dividend?

The dividends of Aceso Life Science Group are distributed in HKD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aceso Life Science Group

Our stock analysis for Aceso Life Science Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aceso Life Science Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.